Professional Documents
Culture Documents
ps vs retencion atr
ps vs retencion atr
1 Department of Orthopaedic and Traumatology, Campus Bio Medico Address for correspondence Mauro Ciuffreda, MD, Department of
University, Rome, Italy Orthopaedic and Traumatology, Campus Bio Medico University,
2 Department of Orthopaedic, Melbourne Institute, University of Via Alvaro del Portillo 21, Rome 00155, Italy
Melbourne, Victoria, Australia (e-mail: maurociuffreda@gmail.com).
J Knee Surg
Abstract The aim of this systematic review is to compare clinical outcome scores, rate of
complications, and range of motion (ROM) of posterior-stabilized (PS) and cruciate-
retaining (CR) total knee arthroplasties (TKAs) both pre- and postoperatively to
establish which of the two kinds of implants have the best efficiency. A comprehensive
Total joint replacement surgery is an important option in most common definitive surgical procedure for end-stage
patients with severe symptomatic osteoarthritis (OA) who OA. It provides marked pain relief and functional improve-
have significant impairment in their quality of life and who ment in patients with severe knee OA.2–4
have failed to respond to nonpharmacological and pharma- TKA was born in 1974, and this field has been in contin-
cological management.1 Total knee arthroplasty (TKA) is the uous evolution yet. However, one of the most important
Idenficaon
Records identified through
retaining (CR) and posterior-stabilized (PS) TKAs have shown database searching
to provide valid pain relief and similar outcomes evaluated (n = 142)
Screening
main difference between the two surgical procedures was
previously shown to be postoperative knee range of motion
Records screened Records excluded
(ROM), although the results varied depending on the (n = 111) (n = 64)
study.5–11
In the physiological knee, the PCL has different kinematic
functions. During flexion, it guides rollback of the femoral
Eligibility
condyles on the tibial plateau, prevents posterior subluxa- Full-text articles Full-text articles
excluded, with
tion of the tibia on the femur in flexion, and plays a decisive assessed for
reasons (n = 10)
eligibility (n = 47)
secondary role in varus/valgus stability. The retention of the
PCL provides possible kinematic and proprioceptive benefits
such as the maintenance of a central stabilizer and joint line
Included
position, and the avoidance of the patellar clunk syndrome Studies included in
Categorical variable data were reported as frequency with TKAs completed using the CR method and 2,816 (52.1%)
percentage. Continuous variable data were reported as mean completed using PS method.
value, with the range between minimum and maximum
values. In all studies, p < 0.05 was considered statistically Outcome Measurements
significant. Several outcome measures were reported in the included
Moreover, a meta-analysis was performed of all rando- studies (►Tables 2 and 3). The most frequently reported
mized level I comparative studies that investigated the two outcomes were the KSOS and the ROM, both used in 32
types of prosthesis: CR and PS TKAs in terms of Knee Society (86.5%) of 37 studies. Other less consistently reported scor-
objective score (KSOS),16 KSFS,16 complications, extension, ing systems were the KSFS, used in 21 (56.8%) of 37studies;
and flexion after surgery. Review Manager (RevMan, version the WOMAC used in 12 (32.4%) of 37 studies; the HSS score
5 for Windows; Cochrane Informatics and Knowledge Man- used in 7 (18.9%) of 37 studies; and the OKS used in 4 (10.8%)
agement Department) was used to calculate the magnitude of 37 studies.
of treatment effect. The test used for meta-analysis to stratify
or match the categorical data is the Mantel–Haenszel’s test. It Outcome Scores
allows an investigator to test the association between a The mean KSOS improved from 45.2 (preoperatively) to 90.3
binary predictor or treatment and a binary outcome such (postoperatively) for the CR group. Similar results were
as case or control status while taking into account the obtained in the PS group, showing a mean KSOS increase
stratification. I2 was calculated as a measure of heterogene- from 43.7 (preoperatively) to 90.8 (postoperatively). The
ity for the main analysis. An I2 value represents the percen- preoperative and postoperative mean values of KSFS were
tage of total variation across studies caused by heterogeneity 45.6 and 76.6, respectively, for the CR group, and were 44.6
Authors Study design (level) Number of Number Number Number Mean age, y (range) BMI (kg/m2) Sex M:F Bone defects Mean Prosthesis type
patients of knees of CR of PS follow-up
CR PS
(y)
Ang et al (2014) 18 Level III 95 100 37 63 CR: 67.7 PS: 67.6 CR: 26.2 CR (7:30); OA, Type II 2 –
Outcomes of PS Compared with CR TKA
Bin Abd Razak et al Level III 195 195 112 83 CR 66 PS 67 CR: 28.4 (3.6) CR OA 2 PFC Depuy
(2013)19 (50–84) (54–40) PS: 26.9 (3.6) (22:90); PS Orthopedic
Longo et al.
(18:65) International
Cates et al (2008)21 Level III (retrospec- 30 30 15 15 CR: PS: CR: 27.4 3.6 CR (5:10); OA, RA, AVN 0.5 NexGen CR-Flex
tive study) 67.8 7.1 66.9 10.5 PS: 28.6 4.1 PS (5:10) high-flexion (Zim-
mer) or Legacy
LPS-Flex high-flex-
ion (Zimmer) by a
single surgeon
(Cates)
Chaudhary et al Level I (RCT, double 78 78 40 38 CR: 69.2 PS: 70.2 CR: 32.4 (5.7) CR OA 2 SCORPIO Stryker
(2008)22 blind) (9.1) (8.4) PS: 30.9 (4.3) (27
females);
PS (22
females)
5
Chen et al (2015) Level III 133 133 33 100 CR: 65 8 PS: 64 7 CR: 28.2 5 CR (5:28); OA 2 67 NexGen, 48
(51–80) (51–81) (19.6–38.8) PS (27:73) PFC, 4 Scorpio, 6
Authors Study design (level) Number of Number Number Number Mean age, y (range) BMI (kg/m2) Sex M:F Bone defects Mean Prosthesis type
patients of knees of CR of PS follow-up
CR PS
(y)
Clark et al (2001)23 Level I (RCT) 128 128 69 59 CR: 57–8,9 PS: 71.2 CR: 83.3 (31.6) – OA, PTA, CR: 2; PS: 3 AMK DePuy/John-
71.8 (12.2) (13.6) PS: 82.1 (38.4) psoriasis son & Johnson
(resurfacing of
the patella was
routine)
Fantozzi et al Level I (randomized 23 23 10 13 CR: 73.9 PS: 67.7 CR: 29.3 CR (2:8); OA GRADE: CR CR 3.9 Optetrak
(2006)26 prospective) (65–82) (50–81) PS: 28.1 PS (2:11) 1.8 (1–3)/PS (1.5–5.75), Exactech
2.5 (1–3) PS 1.85
(0.6–4.3)
27
Hamai et al (2015) Level III 19 24 12 12 CR: 70 9 PS: 75 9 CR: 26.5 3.6 – OA, RA CR: 2, PS: CR TKA (Founda-
PS: 24.9 3.0 2.75 tion knee, Encore
Medical Co.), PS
TKA (NexGen
Complete Knee
Solution Legacy
PS, Knee, Zimmer
Inc.)
28
Han et al (2012) Retrospective cohort 127 186 92 94 CR: PS: CR: 27.5 3.4 – OA 2 NexGen Zimmer
study Level III 67.5 5.7 68.0 5.8 PS: 27.4 4.0
Outcomes of PS Compared with CR TKA
Harato et al (2008)3 Level I (RCT) 189 192 99 93 CR: 68.3 PS: 66.0 CR: 29.8 CR OA 5.5 Genesis II Smith &
(49–89) (44–83) (19.7–43.6); PS: (34:65); PS (5.0–7.3) Nephew
31.4 (21.7–48.5) (32:61)
Kim et al (2009) 29 Level I (randomized 250 500 250 250 CR: PS: 71.6 6 CR: 26.8 3.2; 10:240 OA 2.3 Zimmer
prospective) 71.6 6 PS: 26.8 3.2
Longo et al.
Authors Study design (level) Number of Number Number Number Mean age, y (range) BMI (kg/m2) Sex M:F Bone defects Mean Prosthesis type
patients of knees of CR of PS follow-up
CR PS
(y)
14
Kolisek et al (2009) Level II (prospective 91 91 46 45 CR: 64 PS: 66 (45– CR: 32 (26–43); CR OA, ON, RA 5 (4.5–5.75) SCORPIO Stryker
Lee et al (2012) 30 Retrospective study 131 179 45 134 CR: 65.7 PS: 67.2 CR: 27 2.5; PS: CR (2:43); OA CR: 8.1 57 knees with the
Level III 27 3.3; F-PS: PS (3:37); (5–9.7), PS: Scorpio CR im-
28 4.2 F-PS (7:87) 8.0 (5–12) plants, 50 knees
with the Scorpio
PS implants, and
118 knees with
Outcomes of PS Compared with CR TKA
Maruyama et al Level III (prospective 20 40 20 20 74.3 (65–84) – 8:12 OA 2.6 (2–4.4) PFC DePuy John-
(2004)7 study) son & Johnson
Mouttet and Sourdet Level IV (compara- 104 114 71 43 CR: 76 5 PS: 77 7 CR: 28 4 CR OA: (63CR/ 4.5 EUROP Euros SAS
(2014)8 tive study) (57–87) (57–91) (18–40); PS: (19:47); PS 35PS), PTA:
28 3 (21–36) (11:29) (3CR/4PS),
ON (5 CR/
3PS), RA:
(1PS)
Peters et al (2014) 36 Level III 382 468 240 228 CR: 62 10 PS: 62 10 CR: 33.3 8.8 163:305 CR: OA 215 2 –
(23–86) (23–82) (17.7–79.5); PS: (90%);AS: 201
31.7 7.9 OA (88%)
(17.7–87.9)
Authors Study design (level) Number of Number Number Number Mean age, y (range) BMI (kg/m2) Sex M:F Bone defects Mean Prosthesis type
patients of knees of CR of PS follow-up
CR PS
(y)
37
Sando et al (2015) Level III 360 414 143 271 CR: PS: CR: 31.8 4.8; CR OA 12.3 Genesis Smith &
(prospective) 68.4 8.0 69.3 9.08 PS: 33.0 6.8 (48:95); PS (10.2–14.4) Nephew
(121:150)
Seon et al (2011) 38 Level I (Prospective) 95 95 48 47 CR: PS: CR: 25.8 3.4; CR (4:44); OA 2.25 Zimmer
68.2 7 69.2 6.7 PS: 23.7 2.8 PS (5:42)
Snider and Level I (randomized 200 200 100 100 – – – – OA 2 AMK CR and PS
Macdonald (2009)39 prospective) DePuy, Genesis II
CR and PS Smith &
Nephew
Tanzer et al (2002) 40 Level I (RCT, double 37 40 20 20 CR: 68 PS: 66 CR: 30.7; PS: 30 CR (5:15); OA (36), RA 2 NexGen Zimmer
blind) (range, 51– (range, 52 PS (4:16) (1CR, 2PS), AN (CR) and Legacy
86) -57) (1 PS) Zimmer (PS)
van den Boom et al Level II (prospective) 21 21 9 12 CR: 72 (SD 8) PS: 75 (SD 6) < 35 CR (7:2); OA 0.75 –
(2014)43 PS (5:7)
Vermesan et al Level I (Randomized) 50 50 25 25 CR: PS: CR: 32.6 7.1 CR OA, RA 0.5 Biomet, Zimmer
(2015)6 68.8 6.9 68.4 6.3 PS: 33.4 7.5 (15:10); PS
(22:3)
Victor et al (2005)9 Level I (RCT) 44 44 22 22 CR: 70 7 PS: 70 3 CR: 34.4 CR: (5:17); OA 5 Genesis II Smith &
Outcomes of PS Compared with CR TKA
Wang et al (2004) 44 Level II (prospective 228 267 157 110 CR: 54.5 PS: 55 (20– CR: 28.1 CR (CR) OA 152, 3.5 (2–5.5) PFC Johnson &
clinical study) (31–69) 83) PS: 27.2 (27:110); RA 3, ON 2, Johnson
PS (18:73) OA 91 (PS)
Longo et al.
(Continued)
Discussion
stabilized; GRADE, Grading of Recommendations Assessment, Development and Evaluation; LPS, legacy knee posterior stabilized; OA, osteoarthritis; ON, osteonecrosis; PFC, press-fit condylar; PS, posterior
Abbreviations: AGC, anatomical graded component; AMK, anatomic modular knee; AS, anterior stabilized; AVN, avascular necrosis; BMI, body mass index; CR, cruciate retaining; F-PS, high flexion posterior
PCF DePuy John-
Prosthesis type
Zimmer
improvement in KSFS (p ¼ 0.04), flexion (p < 0.00001), and
–
extension (p ¼ 0.02), which show greater improvements for
the PS group compared with the CR group. This finding is
follow-up
3.4 (41.0
consistent with the literature, which unanimously reports
1.5–4.4 better ROM after PS TKAs.5–7,9,46
Mean
mo)
(y)
OA
Since the KSOS and the KSFS scores are subjective measures,
stabilized; PTA, posttraumatic arthritis; RA, rheumatoid arthritis; RCT, randomized controlled trial; SD, standard deviation; TKA, total knee arthroplasty.
there is need for more objective tools that assess patient
Sex M:F
6:12
difference.
–
PS: 69.2 y
CR: 69.1 y
been multifactorial.
There may be, however, particular primary TKA patient
Number
2,816
76.1
29
20
70.0
29
20
5,407
40
4,445
29
20
Level II (prospective
Level I (Prospective
Mean
Total
Yoshiya et al
(2005)46
Authors
CR PS CR PS CR PS
Bin Abd Razak et al KSS (knee and function – – Preop 34.4 8.0; Preop 34.4 9.0; SF-36 preop SF-36 preop – –
(2013) 19 score), OKS, SF-36, ROM 2 y postop 2 y postop 33.7 10.9; 2 y 33.4 10.9; 2 y
18.7 4.7 19.3 5.3 postop 47.3 9.5 postop
46.9 10.2
Catani et al RSA, KSS, HSS, ROM – – – – Postop HSS: Postop HSS: 1 lateral release 2 lateral release
(2004) 20 86 8 89 7 and patella resur- and patella resur-
facing for anterior facing for anterior
knee pain knee pain
Chaudhary et al ROM, KSFS, WOMAC, pain Pain score (preop: Pain score (preop: – – – – 1 deep infection 1 stiff knee requir-
(2008) 22 score, complication 51.0 17.9, 47.4 16.7, requiring removal ing manipulation
postop: postop: of hardware
85.1 17.6); 83.3 16.7);
functional score functional score
(preop: (preop:
51.6 5.6, 55.8 16.3,
Outcomes of PS Compared with CR TKA
postop: postop:
76.5 0.9) 77.8 17.4)
5
Chen et al (2015) KSFS, KKS, OKS, ROM – – Preop 38 (28.43); Preop 36 (30.43); – – – –
2 y postop 17 2 y 18 (16.23)
Longo et al.
(Continued)
CR PS CR PS CR PS
(2006) 26
Han et al (2012) 28 KSS, HSS, WOMAC, ROM, Preop 51.5 6.2; Preop 52.3 7.7; – – Flexion contrac- Flexion contrac- 2 anteroposterior 1 mediolateral
Longo et al.
complication 2 y postop 2 y postop ture preop 3.2 ture preop 3.6 instability (less laxity (less than 10
9.2 91 11.9 9.6 deg 5.4; 2 y deg 4.9; 2 y than 10 mm) deg)
postop 0.2 postop 0.2
deg 1.5 deg 1.1
Harato et al ROM, KSS, KSFS, WOMAC, Preop Preop – – SF-12 (m) SF-12 (m) 1 infection, 7 stiff 3 infection, 1 stiff
(2008) 3 pain score, complication 26.4 16.3, 23.2 11.9, 54.0 10.9; SF-12 54.7 12.1; SF-12 knee, 2 hemar- knee, 1 hemar-
postop postop 8.5 12.3 (f) 30.3 7.1 (f) 30.4 7.8 throsis, 5 knee throsis, 2 knee
10.4 13.4 pain, 1 lucent line, pain, 1 lucent line,
0 DVT 1 DVT
29
Kim et al (2009) KSS, HSS, WOMAC, flex- 5.5 3.77 4.9 2.98 – – Postop HSS: Postop HSS: 2 anterior femoral 3 anterior femoral
ion, radiographs, 90 19.7 91 16.5 notching, 1 super- notching, 1 super-
complications ficial wound ficial wound
infection infection
Lee et al (2012)30 KSS, HSS, WOMAC Preop: 59 15.4; Preop: 53 16.1; – – – – 1 aseptic loosening 2 aseptic loosening
postop: 18 12.3 postop: 15 9.1
Liu et al (2015) 32 – –
CR PS CR PS CR PS
WOMAC, KSS, ROM, Only graph Only graph Mediolateral laxity Mediolateral laxity 1 necrosis, 0 infec- 2 necrosis, 0 infec-
Kellgren–Lawrence displayed displayed preop 13.2, postop preop 13.4, postop tion, 1 hemarthro- tion, 1 hemarthro-
grading 13.3; anteropos- 13.8; anteropos- sis, 1 DVT, 1 lucent sis, 0 DVT, 1 lucent
terior laxity preop terior laxity preop line, 2 anterior line, 3 anterior
9.1, postop 8.9; 8.9, postop 7.7; knee pain, 2 stiff knee pain, 0 stiff
valgus preop 3.7, valgus preop 3.5 knee knee
postop 6.5 postop 6.3
Lützner et al KSS, OKS, UCLA activity – – 19.0–30.0 at 3 mo/ – UCLA (maximum level 10) demonstrated 2 delayed wound healing. 1 mobilization
(2015) 33 score, ROM 19.0–34.4 at 1 y minor improvement in self-assessed activ- under anesthesia was necessary due to
ity from median level 3 preoperatively to restricted ROM at the 3-mo follow-up. DVT
level 4 postop (1 y) (n ¼ 4), myocardial infarction (n ¼ 1),
implantation of a cardiac pacemaker
(n ¼ 1), postoperative delirium (n ¼ 1),
and gastrointestinal problems (n ¼ 6)
Misra et al (2003) 35 HSS, ROM, satisfaction – – – – HSS: preop (36.2), HSS: preop (38.6), 3 instability, 1 in- 3 instability, 3
rollback loosening postop (81.4) postop (83.6) fection, 2 aseptic aseptic loosening,
loosening, 2 2 stiffness
stiffness
peration, 21 peration, 7
revision, 7 septic, revision, 5 septic, 2
14 aseptic, 6 in- aseptic, 0 instabil-
stabilities, 3 ities, 1 loosening
loosening
Longo et al.
CR PS CR PS CR PS
Sando et al KSS (function and knee Function preop Function preop – – – – 2 patella resurfa- 3 patella resurfa-
38
Seon et al (2011) HSS, WOMAC, ROM, Postop: Postop: – – HSS: 94.7 4.3 HSS: 93.9 4.7 None detected None detected
Radiographs 28.4 13.8 27.9 12.2
van den Boom et al KSS, ROM, WOMAC, knee Preop: 53 20; Preop: 46 18; – – – – – –
(2014) 43 moment (nm/kg) postop 15 10 postop: 15 12
9
Victor et al (2005) KSS, KSFS, ROM, pain Pain (preop Pain (preop – – – – – –
score, WOMAC 8.8 3.2, postop 10.8 3.3,
1.8 3.1); func- postop 4.1 6.2),
tion (preop function (preop
34.3 10.2, 38.5 11.0,
postop 8.7 6.9) postop
2.1 14.9)
Abbreviations: CR, cruciate retaining; DVT, deep vein thrombosis; HSS, Hospital for Special Surgery knee score; KSFS, Knee Society functional score; KSS, Knee Society score; OKS, Oxford Knee Score; Postop,
postoperative; Preop, preoperative; PS, posterior stabilized; ROM, range of motion; RSA, Roentgen stereophotogrammetric analysis; SD, standard deviation; SF-36, Short Form health survey; UCLA, University of
Overall complications: 213 in 5,407 knees
perioperative outcome. While Vermesan et al (2015)6 and
–
demonstrated in the PS group (548 216 mL in the PS group
tions: 17 of 37 (45.9%)
compared with 502 186 mL in the CR group),49 based on
the pre- and postoperative hematocrit levels at discharge in
Complications
(3.9%)
CR
between the two groups (PS 0.41 vs. CR 0.37). Once again,
OKS: 4 of 37 (10.8%)
WOMAC SD
position), ROM
Authors KSS clinical (SD) KSFS (functional) (SD) ROM (deg) (SD)
CR PS CR PS CR PS
Preop Postop Preop Postop Preop Postop Preop Postop Preop Postop Preop Postop
Ang et al 23 88 (< 0.001)a 30 87 (< 0.001)a 45 60 (< 0.001) a 45 65 (< 0.001)a 132 114 (< 0.001) a 132 126 (0.007)a
18
(2014)
Bin Abd Razak 36.8 (19.8) 86.2 (13.7) 42.2 (19.5) 86.4 (10.3) 55 (18.1) 72.7 (21.4) 56 (19.3) 71.8 (15.5) 118 (19) 114 (15) 121 (18) 122 (10)
et al (2013)19
Catani et al 52 (17) 89 (10) 47 (12) 90 (9) 55 (25) 81 (17) 51 (17) 76 (19) 106 (12) 97 (15) 106 (21) 114 (21)
(2004)20
Cates et al 48.7 (12.3) 97.3 (3.0) 44.1 (12.9) 96.2 (3.0) 31.0 (14.3) 81.0 (24.0) 25.0 (12.2) 92.0 (10.5) 117 (15) 126 (9) 110 (17) 125 (10)
(2008)21
Longo et al.
Chaudhary et – – – – 51.6 (15.6) 76.5 (20.9) 55.8 (16.3) 77.8 (17.4) Flex: 116.4 Flex: 105.9 (13.0), Flex: 111.5 Flex: 105.8
al (2008)22 (13.8), Ext: 6.6 Ext: 1.2 (2.5) (15.3), Ext: 7.2 (13.5), Ext: 2.2
(6.2) (8.4) (3.5)
b b b b b b b b b b b
Chen et al 43 (18, 57) 84 (72, 92) 40 (26, 55) 86 (81, 90) 55 (45, 65) 75 (58, 80) 50 (45, 60) 70 (55, 80) 101 (90, 116) 110 (90, 118) 115 (100, 121) 118 (108, 125)b
5
(2015)
Conditt et al – 94.6 (2.4) – 89.4 (3.7) – – – – 109 (8) 121.4 (1.9) 100 (5) 121.9 (1.8)
(2004)24
Delport 33 96 38 99 42 94 42 97 – – – –
(2013)2
Hamai et al – 93 (6) – 93 (6) – 78 (15) – 75 (14) – Flex: 119 (11), Ext: – Flex: 125 (7),
(2015)27 1 (2) Ext: 3 (3)
Han et al 51.7 (8.5) 97.9 (3.1) 53.7 (10.0) 97.6 (3.2) – – – – 124.5 (15.3) 131 (10.5) 128.4 (13.4) 132.7 (7.0)
(2012)28
46.7 (16.9) 90.8 (13) 44.3 (17.6) 90.4 (15.7) 47.2 (17.2) 69.6 (19.7) 50.8 (13.7) 74.9 (18.7)
Harato et al Flex: 113.3 Flex: 113.7 (12.8), Flex: 110.1 Flex: 117 (13.5),
(2008)3 (11.6), Ext: 5.6 Ext: 0.8 (2.1) (13.6), Ext: 5.3 Ext: 1.6 (1.5)
(5.7) (6.4)
Kim et al – 94 (14.5) – 95 (15.3) – 80.2 (19.7) – 83.7 (19.6) – 124.3 (9.2) – 129 (5.2)
(2009)29
Kolisek et al 42 (20, 73)c 93 (55, 100)c 38 (20, 70)c 94 (60, 100) c 36 (10, 60) c 71 (15, 100)c 32 (10, 70)c 73 (32, 100)c – 125 (100, 140)c – 118 (87, 135) c
(2009)14
Lee et al 40 (17.8) 93 (9.7) 38 (17.3) 94 (5.6) 42 (15.4) 73 (25.0) 42 (14.3) 80 (19.5) 112 (14.6) 115 (15.8) 109 (20.7) 121 (11.9)
(2012)30
Liu et al 46 89.5 46 90.1 45.2 65.6 43.7 67.0 Flex: 110.6, Ext: Flex: 110, Ext: 0.7 Flex: 114.4, Ext: Flex: 116.6, Ext:
(2015)32 5.1 4.8 0.7
Lützner et al OTP: preop 43.5 (18.3), postop 86.0 (14.6) OTP: preop 41.5 (18.0), postop 62.9 (22.5) OTP Flex: 105.0 (14.1) OTP Flex: 113.5 (14.0)
(2015)33
Maruyama 42.8 (9.9) 89.8 (7.2) 43.6 (10.1) 89.5 (8.9) OTP: preop 55.3 (11.8), postop 83.3 (11.3) 112.5 (20.9) 122.2 (14.8) 112.2 (22.5) 129.6 (13.9)
et al (2004)7
Matsumoto et 55.4 (28, 74)c 95.7 (84, 100) c 58.0 (11, 76)c 92.9 (81, 100)c 54.7 (35, 82) c 88.6 (72, 100)c 55.9 (30, 82)c 84.8 (72, 100)c 114.2 (75, 140)c 125.3 (95, 140)c 114.2 (75, 140)c 121.6 (100,
al (2012)34 135)c
Misra et al – – – – – – – – 82 (30, 112) c 107.5 (60, 125)c 84.5 (30, 110)c 105.2 (60, 115) c
35
(2003)
Mouttet and 31 (14) 85 (12) 26 (15) 87 (8) 35 (16) 70 (27) 32 (13) 67 (28) 115 (11) 112 (11) 113 (16) 115 (10)
Sourdet
(2014)8
Sando et al 41.9 (14.1) 92.4 (12.2) 40.2 (13.6) 93.0 (10.4) 44.7 (15.2) 56.5 (32.5) 47.7 (13.7) 69.5 (25.0) Flex: 112.5 Flex: 113.5 (13.4), Flex: 109.1 Flex: 116.7
(2015)37 (13.0), Ext: 3.9 Ext: 0.5 (2.0) (17.4), Ext: 6.4 (12.8), Ext: 0.5
(4.7) (8.3) (2.3)
Snider and – – – – – – – – – – – –
Macdonald
(2009)39
Tanzer et al 47 (17) 90 (12) 44 (11) 93 (11) 34 (13) 73 (24) 38 (13) 76 (28) 110 (12) 112 (13) 101 (23) 111 (17)
Longo et al.
(Continued)
Thomsen et al – – – – – – – – 116 (70, 140)c 120 (104, 146)c 118 (80, 140)c 127 (107, 146)c
41
(2013)
Tsuneizumi – 91.7 (3.4) – 91.6 (7.1) – 81.8 (12.8) – 80.0 (8.1) – 116.3 (11.0) – 118.9 (11.2)
et al (2008)42
van den Boom 55 (13) 77 (10) 52 (8) 83 (7) – – – – 119 (16) 113 (11) 119 (13) 120 (7)
Victor et al 38.0 (15.1) 82.2 (2.2) 37.2 (21.7) 77.9 (13.8) 50.5 (13.4) 83.6 (15.3) 39.1 (18.5) 74.8 (27.9) 109 (11) 114 (10) 103 (9) 117 (7)
(2005)9
Wang et al 51.7 (20.3) 90.7 (5.3) 45.9 (20.7) 91.0 (4.8) 41.0 (19.9) 84.2 (20.8) 39.2 (21.9) 87 (19.6) Flex: 114 (21.1), Flex: 110, Ext: 1.0 Flex: 110 (20), Flex: 112,
Outcomes of PS Compared with CR TKA
Yagishita et al 46.6 (9.7) 95.4 (4.1) 48.6 (11.3) 93.5 (5.5) – – – – 132.9 (16.5) 125.4 (10.9) 133.1 (18.5) 129.3 (11.7)
(2012)45
(2005)46
Mean 45.2 90.3 43.7 90.8 45.6 76.6 44.6 77.6 115.0 114.4 115.2 119.4
Statistical ana- PS vs. CR KSS improvement (OR, 0.17; 95% CI, 1.24 to 1.57; p ¼ 0.82) PS vs. CR KSFS improvement (OR, 2.77; 95% CI, 5.36 to 0.18; PS vs. CR flexion improvement (OR, 4.70; 95% CI, 5.81 to 3.60; p < 0.00001a);
a
lysis: PS vs. CR p ¼ 0.04 ) PS vs. CR extension improvement (OR, 0.57; 95% CI, 1.05 to 0.09; p ¼ 0.02a)
Number of KSS: 32 of 37 studies (86.5%) KSFS: 21 of 37 studies (56.8%) ROM: 32 of 37 studies (86.5%)
studies
Abbreviations: CI, confidence interval; CR, cruciate retaining; Ext, extension; Flex, flexion; KSFS, Knee Society functional score; KSS, Knee Society Score; OR, odds ratio; OTP, only total provided; Postop,
postoperative; Preop, preoperative; PS, posterior stabilizing; ROM, range of motion; SD, standard deviation.
a
p-Value (statistically significant) of each outcome measure compared with preoperative.
b
Interquartile range.
c
Range.
Fig. 2 Forest plot of postoperative KSOS after CR and PS procedures. CI, confidence interval; CR, cruciate-retaining; KSOS, Knee Society
objective score; M-H, Mantel–Haenszel; PS, posterior-stabilized; SD, standard deviation.
Fig. 4 Forest plot of postoperative flexion after CR and PS procedures. CI, confidence interval; CR, cruciate-retaining; M-H, Mantel–Haenszel; PS,
posterior-stabilized; SD, standard deviation.
Fig. 5 Forest plot of postoperative extension after CR and PS procedures. CI, confidence interval; CR, cruciate-retaining; M-H, Mantel–Haenszel;
PS, posterior-stabilized; SD, standard deviation.
Fig. 6 Forest plot of postoperative complications after CR and PS procedures. CI, confidence interval; CR, cruciate-retaining; M-H, Mantel–
Haenszel; PS, posterior-stabilized.
12 Rosenberg AG. Posterior cruciate ligament retention in total knee 30 Lee SM, Seong SC, Lee S, Choi WC, Lee MC. Outcomes of the
arthroplasty. In: Scott WN, ed. Insall & Scott Surgery of the Knee, different types of total knee arthroplasty with the identical
5 ed. London, England: Churchill Livingstone; 2012:1125–1131 femoral geometry. Knee Surg Relat Res 2012;24(04):214–220
13 Bercik MJ, Joshi A, Parvizi J. Posterior cruciate-retaining versus 31 Li N, Tan Y, Deng Y, Chen L. Posterior cruciate-retaining versus
posterior-stabilized total knee arthroplasty: a meta-analysis. posterior stabilized total knee arthroplasty: a meta-analysis of
J Arthroplasty 2013;28(03):439–444 randomized controlled trials. Knee Surg Sports Traumatol Ar-
14 Kolisek FR, McGrath MS, Marker DR, et al. Posterior-stabilized throsc 2014;22(03):556–564
versus posterior cruciate ligament-retaining total knee arthro- 32 Liu HG, Zhu W, Zhang ZX. Comparison of outcomes after bilateral
plasty. Iowa Orthop J 2009;29:23–27 simultaneous total knee arthroplasty using posterior-substitut-
15 Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for ing versus cruciate-retaining prostheses. Saudi Med J 2015;
reporting systematic reviews and meta-analyses of studies that 36(02):190–195
evaluate health care interventions: explanation and elaboration. 33 Lützner J, Firmbach FP, Lützner C, Dexel J, Kirschner S. Similar
J Clin Epidemiol 2009;62(10):e1–e34 stability and range of motion between cruciate-retaining and
16 Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society cruciate-substituting ultracongruent insert total knee arthro-
clinical rating system. Clin Orthop Relat Res 1989;(248):13–14 plasty. Knee Surg Sports Traumatol Arthrosc 2015;23(06):
17 Akasaki Y, Matsuda S, Miura H, et al. Total knee arthroplasty 1638–1643
following failed high tibial osteotomy: mid-term comparison of 34 MatsumotoT, Muratsu H, Kubo S, Matsushita T, Kurosaka M, Kuroda
posterior cruciate-retaining versus posterior stabilized prosthe- R. Intraoperative soft tissue balance reflects minimum 5-year
sis. Knee Surg Sports Traumatol Arthrosc 2009;17(07):795–799 midterm outcomes in cruciate-retaining and posterior-stabilized
18 Ang CL, Fook S, Chia SL, Chin PL, Lo NN, Yeo SJ. Unconstrained total knee arthroplasty. J Arthroplasty 2012;27(09):1723–1730
arthroplasty in type II valgus knees: posterior stabilized or 35 Misra AN, Hussain MR, Fiddian NJ, Newton G. The role of the
cruciate retaining? Knee Surg Sports Traumatol Arthrosc 2014; posterior cruciate ligament in total knee replacement. J Bone Joint
22(03):666–673 Surg Br 2003;85(03):389–392
under passive and weight-bearing conditions. J Arthroplasty cruciate-ligament-stabilized total knee arthroplasties. Knee
2005;20(06):777–783 Surg Sports Traumatol Arthrosc 2014;22(08):1865–1869
47 Nguyen LC, Lehil MS, Bozic KJ. Trends in total knee arthroplasty 49 Mähringer-Kunz A, Efe T, Fuchs-Winkelmann S, Schüttler KF,
implant utilization. J Arthroplasty 2015;30(05):739–742 Paletta JR, Heyse TJ. Bleeding in TKA: posterior stabilized vs.
48 Cankaya D, Ozkurt B, Aydin C, Tabak AY. No difference in blood loss cruciate retaining. Arch Orthop Trauma Surg 2015;135(06):
between posterior-cruciate-ligament-retaining and posterior- 867–870